Bio-Techne Lands Government Contract for Genomic Prostate Cancer Test

Mar 18, 2020

|

NEW YORK – Bio-Techne on Wednesday said that the General Services Administration (GSA) has awarded a 10-year reimbursement contract to its Exosome Diagnostics laboratory for the ExoDx Prostate (EPI) test.

The contract took effect today, providing 9 million additional men access to the urine-based genomic EPI test for early detection of prostate cancer, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

Bio-Techne Lands Government Contract for Genomic Prostate Cancer Test

To read the full story....

Breaking News

Cancer Genetics Q2 Revenues Drop 5 Percent

IsoPlexis Partnering With Columbia to Study Immune Response to SARS-CoV-2

Pro-Lab Diagnostics Nabs FDA Emergency Use Authorization for Molecular SARS-CoV-2 Test

HHS Invests $6.5M in Aegis Sciences, Sonic Healthcare USA to Expand Coronavirus Testing Capacity

Myriad Genetics Q4 Revenues Plummet 57 Percent on Coronavirus Pandemic Pressures

Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO

Recent Headlines from
Precision Oncology News

Basket Trial Data Supports Further Study of Lynparza, Imfinzi Regimen in BRCA-Mutated Breast Cancer

Research Advocates, Leading Docs to Expand Precision Medicine Access With Decentralized Model

Real-World, Umbrella Studies Highlight Challenges of Evaluating Precision Oncology in NSCLC

UCSF Glioblastoma Projects Using Molecular Data to Inform Subtypes, Match Patients to Treatments

Puma's Nerlynx Offers Targeted Treatment Opportunity for HER2-Mutant Cervical Cancer in Basket Trial

The Scan

High Demand

Where They Hail From

Nature Papers Describe Black Mustard Plant Genome, Link Between Autism and Dyslipidemia

All the Vaccines

What's Popular?

Thermo Fisher Scientific Terminates Qiagen Acquisition Agreement

Mission Bio Raises $70M in Series C Funding Round

NanoString Launches NGS Readout for Spatial Transcriptomics, Partners With Illumina on Informatics

Mammoth Biosciences Eyes Multiple Applications for Newly Discovered UC Berkeley CRISPR Proteins

Pacific Biosciences Prices $86.9M Public Stock Offering

Sponsorships